ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis
MONDAY, Nov. 21, 2022 (HealthDay News) — Opioid initiation among patients with rheumatoid arthritis (RA) is associated with similar major adverse cardiovascular events (MACE) and all-cause mortality risk versus nonsteroidal anti-inflammatory drug (NS…
Learn MoreCDC: Flu Has Started Early and With a Punch
MONDAY, Nov. 21, 2022 (HealthDay News) — Flu season has struck the United States hard and early, burdening hospitals that are also coping with a surge in other respiratory viruses, including respiratory syncytial virus (RSV) and COVID-19.The nation h…
Learn MoreMRI-Guided Focused Ultrasound Thalamotomy Aids Essential Tremor Over Five Years
MONDAY, Nov. 21, 2022 (HealthDay News) — Unilateral magnetic resonance imaging (MRI)-guided focused ultrasound (MRgFUS) thalamotomy for medication-refractory essential tremor shows sustained and significant tremor improvement at five years, accordin…
Learn MoreDisparities Seen in Treatment of Middle Ear Infections in U.S. Children
MONDAY, Nov. 21, 2022 (HealthDay News) — Children from socially disadvantaged backgrounds are less likely to receive treatment for otitis media and more likely to experience complications from undertreatment, according to a study published online Nov…
Learn MoreDemand for Mental Health Care Outpacing Capacity
FRIDAY, Nov. 18, 2022 (HealthDay News) — Demand for mental health treatment may be outpacing capacity to provide care, according to survey results released by the American Psychological Association (APA).The 2022 APA COVID-19 Practitioner Impact Surv…
Learn MoreFDA Approves First Drug to Delay Onset of Type 1 Diabetes
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of stage 3 type 1 diabetes in adults and children 8 years and older who currently have stage 2 type 1 …
Learn MoreNew Pfizer Booster Shot Shows Protection Against Emerging Omicron Variants
FRIDAY, Nov. 18, 2022 (HealthDay News) — The updated Pfizer COVID-19 booster shots are proving their mettle against emerging omicron variants, the company announced Friday. The findings from the study were posted on a preprint server online and have …
Learn MoreFDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration is warning consumers to be careful when buying prescription medication online. While some pharmacy websites operate legally and can offer convenience, privacy, and lower c…
Learn MoreDespite Pleas From Pediatric Groups, Biden Balks at Declaring RSV a Health Emergency
FRIDAY, Nov. 18, 2022 (HealthDay News) — The Biden administration on Thursday offered assistance to communities and hospitals dealing with a surge in cases of pediatric respiratory illnesses, but it did not declare a national public health emergency….
Learn MoreNew Tool Can Predict Individual’s Dementia Risk
FRIDAY, Nov. 18, 2022 (HealthDay News) — A risk score tool can accurately predict an individual’s 13-year dementia risk, according to a study published online Nov. 17 in JAMA Network Open.Lina Ren, from Shenzhen Mental Health Centre in China, and col…
Learn More